

Breo Ellipta can interact with certain medications, supplements, and foods. Learn the major and moderate interactions and what to tell your doctor.
If you take Breo Ellipta (fluticasone furoate/vilanterol), you need to know which other medications, supplements, and foods can interact with it. Some interactions can reduce Breo's effectiveness. Others can increase your risk of serious side effects.
This guide covers the most important interactions to watch for and what information your doctor needs from you.
Breo Ellipta contains two active ingredients, and each one can interact with different substances:
These interactions are the most clinically significant and may require avoiding the combination or close monitoring:
These medications block the enzyme that breaks down fluticasone, causing it to accumulate in your body. This can lead to Cushing's syndrome (excess cortisol) and adrenal suppression:
If you need one of these medications, your doctor may choose an alternative to Breo or closely monitor you for signs of excess corticosteroid effects (weight gain, moon face, easy bruising, high blood sugar).
These medications can potentiate the cardiovascular effects of vilanterol, increasing the risk of rapid heartbeat, elevated blood pressure, and arrhythmias:
If you take any of these, your doctor needs to weigh the risks carefully before prescribing Breo.
Beta-blockers can block the bronchodilating effect of vilanterol and may cause severe bronchospasm in patients with asthma or COPD:
If you have asthma and need a beta-blocker for heart conditions, your doctor will typically choose a cardioselective one at the lowest effective dose.
Do not use Breo with another LABA-containing product. Using two LABAs together increases the risk of cardiovascular side effects (rapid heart rate, arrhythmias) and overdose. This includes:
These interactions are less dangerous but still worth discussing with your doctor:
Loop diuretics like furosemide (Lasix) and thiazide diuretics like hydrochlorothiazide (HCTZ) can lower potassium levels. Since vilanterol can also lower potassium, the combination may worsen hypokalemia, which can cause muscle weakness, cramps, and heart rhythm changes.
Vilanterol may contribute to QT prolongation (a heart rhythm abnormality). Use caution if you also take medications known to prolong the QT interval, such as:
These don't block CYP3A4 as strongly but may still increase fluticasone levels:
Over-the-counter products can also interact with Breo:
Grapefruit juice is a CYP3A4 inhibitor and could modestly increase fluticasone levels. However, because Breo is inhaled (not swallowed), the clinical significance is low. Most doctors don't restrict grapefruit with Breo, but it's worth mentioning if you drink it regularly.
There are no other significant food interactions with Breo Ellipta.
Before starting Breo, make sure your doctor knows about:
Keeping your doctor and pharmacist fully informed is the best way to avoid dangerous interactions. If you're ever prescribed a new medication by a different doctor, remind them that you take Breo Ellipta.
Breo Ellipta is generally safe when used as directed, but its two active ingredients can interact with a variety of other medications. The most important interactions to avoid are strong CYP3A4 inhibitors (which can cause systemic steroid effects), other LABAs (which can cause cardiac overdose), and beta-blockers (which can block Breo's bronchodilating benefit).
When in doubt, ask your pharmacist to run an interaction check every time you start a new medication. And for more about Breo's safety profile, read our side effects guide.
Looking for Breo at your pharmacy? Search Medfinder to check local availability.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.